P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA

P1028: PTG-300 (RUSFERTIDE) TREATMENT INTERRUPTION REVERSES HEMATOLOGICAL GAINS AND RESTORES THERAPEUTIC BENEFIT ON REINITIATION IN SUBJECTS WITH POLYCYTHEMIA VERA

Bibliographic Details
Main Authors: A. Kuykendall, M. Kremyanskaya, Y. Ginsburg, N. Pemmaraju, E. Ritchie, J. Gotlib, F. Valone, S. Khanna, S. Gupta, R. Hoffman, S. Verstovsek
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/01.HS9.0000846980.34790.f7

Internet

http://journals.lww.com/10.1097/01.HS9.0000846980.34790.f7

Similar Items